Top Tech Startups in Lebanon in 2024

Spiritual Data helps people of all beliefs to unite in an unbiased examination of truth. We do this through relating spiritual experiences and research to spiritual hypotheses and using statistical methods to determine the most likely conclusions. Technology automates this process.

We are Wunderman Thompson -- a creative, data and technology agency built to inspire growth for ambitious brands.

Our mission is to create remote work opportunities for displaced individuals in Lebanon and neighboring countries affected by recent humanitarian crises. By connecting skilled professionals from these regions with employers worldwide, we aim to empower them to rebuild their lives, support their families, and contribute their talents to the global workforce.

A marketing agency built on the perfect union of marketers and engineers. Technology has transformed consumer lives A new breed of brands such as Google, Amazon, Netflix and Airbnb have captured consumers’ hearts & minds by disrupting the status quo across all sectors. These brands have defined higher standards of customer experience by continuously improving their products and services through digital media, data & AI. All brands must now live up to these new standards. Their strategic mediation and operational skills will allow you to take a fresh look at the project that you’ve entrusted us with.

Averroes.ai is a generalized platform that focuses on automating key manufacturing processes using AI and data analytics. Our platform offers three main products: Visual Inspection: Our visual inspection product uses advanced algorithms to detect defects in real-time on a wide range of products, including electronics, food, and automotive components. Our solution can be easily integrated into existing production lines and can significantly reduce the number of defective products that reach the end customer. Equipment Health Monitoring: Our equipment health monitoring product uses anomaly detection and predictive maintenance techniques to identify and diagnose problems in industrial systems. This allows our clients to prevent downtime, reduce maintenance costs, and extend the life of their equipment. Data Platform: Our data platform is designed to streamline the process of data gathering, management and analytics. It simplifies the integration of data from multiple sources and system

Nabta Health (nabtahealth.com) discovers new ways for women to prevent, identify and manage non-communicable diseases (NCDs). The growing epidemic of NCDs threatens the ambition of countries around the world to achieve sustainable, universal access to health and universal health coverage for their populations. NCDs also leave populations more susceptible to communicable diseases such as COVID-19. Moreover, NCDs remain underesearched and underserved in women. Until the mid-1990s, clinical research and clinical trials largely excluded women. Today, women using drugs that were approved pre-1994, are 50–75% more likely than men to suffer adverse reactions to those therapies. Ironically, a significant proportion of the drugs in this category are those designed to treat or manage NCDs. Examples include statins and potassium channel-blockers used to manage cardiovascular disease or hypoglycaemic drugs such as Rezulin used to control diabetes. Standardising and personalising the ways in which women identify and manage NCDs in the context of their own lifestyles and health goals, and through the use of applied machine learning and Artificial Intelligence, will improve clinical outcomes and make cutting-edge healthcare affordable and accessible for all women. Nabta’s unique model of hybrid healthcare seamlessly combines digital health with traditional healthcare to improve health outcomes in women living with NCDs. Nabta’s first hybrid care pathway supports women in preventing, identifying and managing Polycystic Ovary Syndrome (PCOS). PCOS is a hormonal disorder responsible for 70% of female fertility issues. Women who use Nabta’s platform will be able to obtain a formal diagnosis of PCOS within 90 days versus the global average of 2.5 years.